课题基金 / 基金详情

RESPONSE OF MAMMALIAN CELLS TO HALOGENATED PYRIMIDINES

RESPONSE OF MAMMALIAN CELLS TO HALOGENATED PYRIMIDINES
哺乳动物细胞对卤代嘧啶的反应
批准号:
3874412
负责人:
J B MITCHELL
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

J B MITCHELL的其他基金

相似基金

相关文献

中文摘要
翻译
当某些卤化嘧啶如溴脱氧尿嘧啶(BrdUrd)和
英文摘要
When certain halogenated pyrimidines such as bromodeoxyuridine (BrdUrd) and iododeoxyuridine (IdUrd) are incorporated into cellular DNA, cells become more sensitive to ionizing radiation and chemotherapy drugs. This observation has led to several clinical studies over the years and recently at the NCI to evaluate whether selective sensitization of tumors could be achieved by IdUrd infusion followed by radiation. An important question arises in these studies regarding the extent to which the drug is incorporated into cells. Work continues to develop techniques to quantify IdUrd incorporation into tumor and normal tissues. The IdUrd monoclonal antibody has proven useful in flow cytometry studies to accurately predict the labeling index (proportion of cells in S phase) and the laboratory is currently involved (with the clinical IdUrd study) in assessing this potentially important clinical parameter. We have obtained biopsied material from at least 10 patients who have received protracted IUdR intravenous infusion. Our findings to date have been that the replacement of thymidine with IUdR has been relatively low from most all patients ranging from 1-10%. However, it is to early to make a statement regarding the extent of replacement with the overall radiotherapy treatment outcome. We will continue to collect and evaluate IUdR replacement data from patients over the next year. Of significance was the observation that one patient who had received a five day infusion of IUdR with a replacement of 10% had a dramatic complete response of a large bulky head and neck lesion. Use of the IUdR antibody and image analysis has enabled us to assess each patient with respect to the heterogeneity of lUdR incorporation. We have automated this process such that it is feasible to determine a labelling index and a measure of heterogeneity from an entire tissue section. In addition to use of the lUdR antibody we are also using the Ki-67 antibody which should complement our studies by giving us an estimate of the growth fraction of the tumor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NITROXIDES AS PROTECTORS AGAINST OXIDATIVE STRESS
RADIOSENSITIZATION OF AERATED AND HYPOXIC MAMMALIAN CELLS
  • 批准号:
    4692099
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    J B MITCHELL
  • 依托单位:
RADIOSENSITIZATION AND CHEMOSENSITIZATION OF AERATED AND HYPOXIC MAMMALIAN CELLS
  • 批准号:
    3838050
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    J B MITCHELL
  • 依托单位:
RADIOSENSITIZATION AND CHEMOSENSITIZATION OF AERATED AND HYPOXIC MAMMALIAN CELLS
  • 批准号:
    3874409
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    J B MITCHELL
  • 依托单位:
海外基金